Cargando…

Hydroxychloroquine overcomes cabergoline resistance in a patient with Lactotroph Pituitary neuroendocrine tumor: a case report

OBJECTIVE: A 22-year-old man complaining erectile dysfunction underwent transsphenoidal surgery for a 2.7 cm sellar mass with total resection and was confirmed at pathology to have a lactotroph pituitary neuroendocrine tumor (PiNET). Postoperatively, the patient’s PRL remained at high level and ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shaojian, Han, Changxi, Lou, Xiaohui, Wu, Zhe Bao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379538/ https://www.ncbi.nlm.nih.gov/pubmed/35983516 http://dx.doi.org/10.3389/fendo.2022.955100

Ejemplares similares

Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
por: Han, Changxi, et al.
Publicado: (2021)

The Role of Cyclic Nucleotides in Pituitary Lactotroph Functions
por: Kucka, Marek, et al.
Publicado: (2013)

Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors
por: Wang, Liangbo, et al.
Publicado: (2023)

Sarcomatous Transformation of a Medically Treated Lactotroph Pituitary Neuroendocrine Tumor?
por: Terry, Merryl, et al.
Publicado: (2023)

Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Pirchio, Rosa, et al.
Publicado: (2021)

Calcium-Prolactin Secretion Coupling in Rat Pituitary Lactotrophs Is Controlled by PI4-Kinase Alpha
por: Kučka, Marek, et al.
Publicado: (2021)

Pseudocapsule and pseudocapsule-based extracapsular resection in pituitary neuroendocrine tumors
por: Wang, Xiao Bin, et al.
Publicado: (2022)

DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
por: Mangili, Federica, et al.
Publicado: (2022)

Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability
por: Wierinckx, Anne, et al.
Publicado: (2018)

Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor
por: Luo, Peiqiong, et al.
Publicado: (2020)

Refractory lactotroph adenomas
por: Urwyler, Sandrine A., et al.
Publicado: (2023)

Intranasal 15d-PGJ2 inhibits the growth of rat lactotroph pituitary neuroendocrine tumors by inducing PPARγ-dependent apoptotic and autophagic cell death
por: Li, Zongyang, et al.
Publicado: (2023)

Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline
por: Ghadirian, Hesam, et al.
Publicado: (2018)

Effect of E-cadherin Expression on Hormone Production in Rat Anterior Pituitary Lactotrophs In Vitro
por: Kusumoto, Kenji, et al.
Publicado: (2010)

Paliperidone and aripiprazole differentially affect the strength of calcium-secretion coupling in female pituitary lactotrophs
por: Kucka, Marek, et al.
Publicado: (2015)

Expression of Prolactin Receptor mRNA in Lactotrophs and Somatotrophs of the Chicken Anterior Pituitary Gland
por: Kaneda, Hiromi, et al.
Publicado: (2018)

Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment
por: Wu, Jiangping, et al.
Publicado: (2023)

Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas
por: Wu, Zerui, et al.
Publicado: (2021)

Pituitary Metastasis of Lung Neuroendocrine Carcinoma Mimicking Pituitary Adenoma:Case Report and Literature Review
por: Liu, Xiaohai, et al.
Publicado: (2021)

Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly
por: Tomasik, Agnieszka, et al.
Publicado: (2022)

Somatotrophs and lactotrophs: an immunohistochemical study of Gallus domesticus pituitary gland at different stages of induced moult
por: Sandhu, M.A., et al.
Publicado: (2010)

Lactotrophs: The new and major source for VEGF secretion and the influence of ECM on rat pituitary function in vitro
por: ALFER, JOACHIM, et al.
Publicado: (2015)

Cabergoline-induced Mania in a Patient of Pituitary Microadenoma
por: Mohapatra, Satyakam, et al.
Publicado: (2017)

Thyrotropin-Secreting Pituitary Adenoma Successfully Treated With Cabergoline
por: Saand, Aisha R, et al.
Publicado: (2021)

Sellar Glomus Tumor Misdiagnosed as Pituitary Adenoma: A Case Report and Review of the Literature
por: Cheng, Yijun, et al.
Publicado: (2022)

Editorial: Resistance to Medical Therapy in Pituitary Tumors
por: Auriemma, Renata S., et al.
Publicado: (2022)

PMON171 DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Pituitary Neuroendocrine Tumoral Cells
por: Mangili, Federica, et al.
Publicado: (2022)

Comparison of unitary exocytic events in pituitary lactotrophs and in astrocytes: modeling the discrete open fusion-pore states
por: Kabaso, Doron, et al.
Publicado: (2013)

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain
por: Lamas, Cristina, et al.
Publicado: (2023)

Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors
por: Wen, Siqi, et al.
Publicado: (2021)

Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors
por: Gil, Joan, et al.
Publicado: (2023)

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease
por: Feelders, Richard A., et al.
Publicado: (2023)

Treatment of Postsurgical Clinically Nonfunctioning Pituitary Adenomas Remnants With Cabergoline
por: Vieira, Marina C M, et al.
Publicado: (2021)

Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
por: Pivonello, Claudia, et al.
Publicado: (2022)

Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile?
por: Vilar, Lucio, et al.
Publicado: (2015)

Differential Regulation of Granule-to-Granule and Granule-to-Plasma Membrane Fusion during Secretion from Rat Pituitary Lactotrophs
por: Cochilla, Amanda J., et al.
Publicado: (2000)

SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth via Targeting VEGFA
por: Wang, Xiaoyu, et al.
Publicado: (2020)

Neuropsychiatric Effects in Patients With Invasive Prolactinomas Treated With Cabergoline
por: Calva-González, Metztli, et al.
Publicado: (2023)

A Case of an Immature PIT1-Lineage Pituitary Neuroendocrine Tumor of the Nasopharynx
por: Peters, Jessica, et al.
Publicado: (2023)

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
por: Singh, Pratibha, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kqaq1oaka6ra56r7ebafh002qj